NYSE: MDTMedtronic plc Stock
$112.27+2.03 (+1.84%)
Updated Dec 7, 2021
MDT Price
$112.27
Fair Value Price
N/A
Market Cap
$144.24B
52 Week Low
$105.02
52 Week High
$135.89
P/E
32.17x
P/B
2.77x
P/S
5.07x
PEG
1.26x
Dividend Yield
2.16%
Revenue
$31.80B
Earnings
$4.70B
Gross Margin
67.4%
Operating Margin
17.75%
Profit Margin
14.8%
Debt to Equity
0.76
Operating Cash Flow
$7B
Beta
0.9
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
High
Medium
Low
52
Industry average
Reasons for this score
MDT ($112.27) is trading below its intrinsic value of $337.00, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
MDT is good value based on its earnings relative to its share price (32.17x), compared to the US market average 37.78x)
Valuation
MDT is poor value based on its earnings relative to its share price (32.17x), compared to the US Medical Devices industry average (25.93x)
Valuation
MDT News
Valuation
MDT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
32.17x
Industry
25.93x
Market
37.78x
MDT is good value based on its earnings relative to its share price (32.17x), compared to the US market average 37.78x)
Valuation
MDT is poor value based on its earnings relative to its share price (32.17x), compared to the US Medical Devices industry average (25.93x)
Valuation
MDT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.77x
Industry
4.97x
MDT is good value based on its book value relative to its share price (2.77x), compared to the US Medical Devices industry average (4.97x)
Valuation
MDT price to earnings growth (PEG)
For valuing profitable companies with growth potential
MDT is poor value relative to its rate of earnings growth, measured by PEG ratio (1.26x)
Valuation
MDT's financial health
Profit margin
Revenue
$7.8B
Net Income
$1.3B
Profit Margin
16.7%
MDT's Earnings (EBIT) of $5.64B can safely cover interest payments on company debt ($25.62B)
Financials
MDT's profit margin has increased (+2.1%) in the last year from (12.7%) to (14.8%)
Financials
Assets to liabilities
Assets
$91.8B
Liabilities
$39.6B
Debt to equity
0.49
MDT's short-term assets ($22.73B) exceed its short-term liabilities ($7.80B)
Financials
MDT's long-term liabilities ($31.79B) exceed its short-term assets ($22.73B)
Financials
MDT's debt relative to shareholder equity (0.76) has decreased or remained constant compared to 5 years ago (0.96)
Financials
MDT's debt to equity ratio (0.76) is considered high
Financials
Cash flow
Operating
$1.8B
Investing
-$709.0M
Financing
-$1.2B
MDT's operating cash flow ($7.16B) is sufficient to service the company's debt ($25.62B)
Financials
Medtronic Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.